Researchers at Inje University Release New Data on Gastric Cancer [Doxifluridine versus Tegafur/Gime...
Researchers at Inje University Release New Data on Gastric Cancer [Doxifluridine versus Tegafur/Gimeracil/Oteracil (S-1) as adjuvant chemotherapy for patients with gastric cancer after gastrectomy: A propensity score-matched analysis]
About this item
Full title
Researchers at Inje University Release New Data on Gastric Cancer [Doxifluridine versus Tegafur/Gimeracil/Oteracil (S-1) as adjuvant chemotherapy for patients with gastric cancer after gastrectomy: A propensity score-matched analysis]
Publisher
NewsRX LLC
Journal title
Obesity, fitness, & wellness week, 2023-09, p.3980
Language
English
Formats
Publication information
Publisher
NewsRX LLC
Subjects
More information
Alternative Titles
Full title
Researchers at Inje University Release New Data on Gastric Cancer [Doxifluridine versus Tegafur/Gimeracil/Oteracil (S-1) as adjuvant chemotherapy for patients with gastric cancer after gastrectomy: A propensity score-matched analysis]
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A765607186
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A765607186
Other Identifiers
ISSN
1531-6386
How to access this item
Log in as a Library member
